On Wednesday, in the course of current trade, Shares of Twenty-First Century Fox, Inc. (NASDAQ:FOXA), gained 0.46%, and is now trading at $33.56, after analysts at Credit Suisse initiated coverage of the company with an “outperform” rating and a price target of $40.
The firm cited several reasons for its positive coverage initiation. Analysts see the current weak ratings performance at Fox to improve over the next 1-2 years, driving a recovery in ad revenue growth. Also, the company has one of the strongest film slates in the industry, counting the Avatar sequel that is set to come out in 2017.
Twenty-First Century Fox, Inc. operates as a diversified media and entertainment company worldwide. It operates through Cable Network Programming, Television, Filmed Entertainment, and Direct Broadcast Satellite Television segments.
During an Afternoon trade, Shares of DDR Corp. (NYSE:DDR), dipped -0.97%, and is now trading at $16.82.
DDR Corp., declared that President and CEO David J. Oakes will present at the annual NAREIT Investor Forum in New York. The Company’s presentation is planned for Wednesday, June 10, 2015, from 3:30pm - 4:00pm ET.
DDR Corp. is an equity real estate investment trust. It invests in the real estate markets of the United States and Puerto Rico. The firm is in the business of acquiring, owning, developing, redeveloping, expanding, leasing and managing shopping centers. It formerly known as Developers Diversified Realty Corp. DDR Corp is based in Beachwood, Ohio.
Shares of Penn West Petroleum Ltd. (NYSE:PWE), during its Wednesday’s current trading session fell -4.27%, and is now trading at $2.02.
Penn West Petroleum, declared that it has finalized and reached definitive amending agreements with the lenders under its syndicated bank facility and the holders of its senior notes to, among other things, amend its financial covenants as initially revealed by the Company in its press release issued on March 12, 2015 announcing its year-end financial and operational results for 2014.
Since Penn West declared in March that it had reached agreements in principle with its lenders and note-holders, the Company has sold or reached agreements to sell assets for aggregate net proceeds of about $415 million , which comprises $318 million from its formerly declared royalty transactions which were accomplished in early May, and about $97 million from non-core asset dispositions which are predictable to be accomplished by the end of the second quarter of 2015. Following the terms of the amending agreements with its lenders and noteholders, in the event that Penn West completes any asset dispositions preceding to March 30, 2017 , it has committed to use the net proceeds from such asset dispositions to repay at par $650 million of the outstanding principal amounts owing to note-holders, with corresponding pro rata amounts from such asset dispositions to be used to repay any outstanding amounts drawn under its syndicated bank facility.
Penn West Petroleum Ltd. explores for, develops, and produces oil and natural gas properties in western Canada. The company’s properties are located in Alberta, British Columbia, Saskatchewan, Manitoba, and the Northwest Territories, Canada; and Wyoming, the United States.
Finally, St. Jude Medical Inc. (NYSE:STJ), gained 0.32% Wednesday.
St. Jude Medical, declared preliminary results from the ILUMIEN I trial and final results from the ILUMIEN II clinical study. Taken together, the findings from both studies show that with resolution up to 10 times higher than intravascular ultrasound (IVUS), optical coherence tomography (OCT) imaging can assist improve stent selection and deployment, better support clinical decision-making and improve patient outcomes.
Data from both studies were presented recently as late-breaking clinical trials at EuroPCR 2015, and further advance the use of OCT imaging alongside percutaneous coronary intervention (PCI).
During PCI procedures, physicians use diagnostic imaging to make decisions related to stent sizing and to assess how to best keep the artery expanded to restore blood flow to the heart. For patients, this visualization is important, as inappropriate stent sizing can induce trauma to surrounding vascular tissue, while under-expansion can lead to future clotting (thrombosis) or a recurrence of vessel narrowing (restenosis).
Now, data from the ILUMIEN I study has revealed OCT imaging conducted pre- and post-PCI influenced physician decision-making in 65 percent of patients and is associated with reduced rates of myocardial infarction (MI), commonly known as heart attacks. The ILUMIEN II study found that OCT guidance can yield a similar degree of stent expansion, or support full stent deployment, in comparison to IVUS. Stent expansion is viewed as an important predictor of adverse outcomes for patients undergoing PCI, such as blood clotting (thrombosis) or the recurrence of blood flow restriction (restenosis).
St. Jude Medical, Inc., together with its auxiliaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm administration, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
